Today's top 5 stories on CNBC |
Pharma's Market w/ Mike Huckman: Dendreon's Provenge Trial--Big Step On Bumpy Road CNBC reporter Mike Huckman blogs on the latest developments for reader favorite, Dendreon, and the ongoing struggle to get its prostate cancer drug, Provenge, approved by the FDA. Click here to view posting. |
Tune in to CNBC tomorrow to watch the market unfold |
CNBC Investing Tools | |
To unsubscribe to this email click here
If this e-mail was forwarded to you and you would like to subscribe to CNBC's Daily Market Wrap, please click here
No comments:
Post a Comment